Patent · US Expired

Use of a statin derivative in the treatment of eye complaints

US5134124A · kind A · utility

25Cited by

1References

10Claims

0Family size

Assignee

Sanofi · FR

Inventors

Dino Nisato · Pavia, IT
Gerard R. Le Fur · Le Plessis-Robinson, FR

Key dates

Filing date	Jun 4, 1990
Grant date	Jul 28, 1992
Priority date	—
Expiry date	Jun 4, 2010

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of N-(3-pyridylpropionyl)phenylalanylhistidyl (cyclohexyl)statyl-N-(1,3-dihydroxy-2-methylpropyl)isoleucinamide, which has the formula ##STR1## in which: Phe is the (L)-phenylalanine residue, His is the (L)-histidine residue, Ile is the (L)-isoleucine residue and (cyclohexyl)Sta is the cyclohexylstatin residue, i.e. the (3S, 4S)-4-amino-5-cyclohexyl-3-hydroxypentanoic acid residue, for the preparation of drugs useful in the treatment of eye complaints. Application: treatment of eye complaints.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.